Cited by 1Antifungal resistance and susceptibilityOral health in cancer treatmentHIV/AIDS oral health manifestations

Antifungal effect of atorvastatin in comparison with fluconazole on Candida species isolated from patients undergoing head-and-neck radiotherapy

Open access
Golestannejad, Zahra, Dehghan, Parvin, Najafizade, Nadia, Kheirkhah, Mahnaz, Bafrani, Maryam Emami, Tabesh, Adel, Nadian, Farshad, Khozeimeh, Faezeh·2024·Dental Research Journal

Abstract

Background: Head-and-neck radiotherapy can change oral Candida species and lead to the development of refractory oral candidiasis resistant to the commonly prescribed antifungal medications such as fluconazole. Atorvastatin exerts an antifungal effect by inhibiting the synthesis of fungal wall ergosterol and impairing mitochondrial function. This study aimed to compare the antifungal effects of fluconazole and atorvastatin on Candida species isolated from patients undergoing head-and-neck radiotherapy. Materials and Methods: In this clinical in vitro study, swab samples were collected from 33 patients admitted to Isfahan Seyed-O-Shohada Hospital before the onset and 2 weeks after the initiation of radiotherapy. The antifungal effects of fluconazole and atorvastatin were evaluated by the microdilution test according to the Clinical and Laboratory Standards Institute standards, and measuring their minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC). Data were analyzed by the Mann–Whitney U -test and the statistical significance level was considered P < 0.05. Results: The results showed that the MIC24, MIC48, and MFC of fluconazole were significantly lower than those of atorvastatin for Candida albicans , Candida tropicalis , and Candida glabrata both before ( P < 0.001 for all) and during ( P < 0.001 to P = 0.003) radiotherapy. Conclusion: According to the results, fluconazole has antifungal effects comparable to those of atorvastatin, but in much lower doses. Atorvastatin showed optimal antifungal effects but in doses beyond the clinically applicable threshold.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/drj.drj_550_23

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fluconazole has significantly greater potency than ATV against C. albicans, C. tropicalis, and C. glabrata isolated from patients undergoing head and neck radiotherapy, both before and after radiotherapy.

    “While ATV exhibited measurable antifungal effects, fluconazole demonstrated significantly greater potency at substantially lower concentrations against C. albicans , C. tropicalis , and C. glabrata , both before and after radiotherapy.”

    From Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies (2025) · cites this paper as [124]

    The Abstract Results report significantly lower MIC24, MIC48, and MFC values for fluconazole than for atorvastatin against all three named species before and during radiotherapy. The Materials and Methods specify that the later samples were taken two weeks after radiotherapy began, not after the course was completed; the claim’s ‘after radiotherapy’ timing is therefore unsupported. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [16]Katiraee F Teifoori F Soltani M Emergence of azole-resistant Candida species in AIDS patients with oropharyngeal candidiasis in Iran Curr Med Mycol 2015 1 11 6 28680991 PMC5490324

Cited by

Sorted by citations

Authors
Golestannejad, Z., Dehghan, P., Najafizade, N., Kheirkhah, M., Bafrani, M. E., Tabesh, A., Nadian, F., & Khozeimeh, F.
Affiliations
  • Isfahan University of Medical Sciences (IR)
  • Dental Students’ Research Committee, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran
  • Department of Prosthodontics, School of Dentistry, Shahre Kord University of Medical Sciences, Shahre Kord, Iran
Corresponding author
Khozeimeh, Faezeh
Venue
Dental Research Journal
Published
2024-12
Volume
21
Issue
1
Pages
68-68
ISSN
  • 1735-3327 (ISSN-L)
  • 2008-0255
OpenAlex
W4405646038
Cited by
1
References
32
Citations by year
2025: 1
FWCI
0.35
Type
journal article
Language
en
Open access
Locations
  • Dental Research Journal (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Oral health in cancer treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV/AIDS oral health manifestations
Keywords
atorvastatin, fluconazole, antifungal activity, Candida, oral candidiasis, head and neck radiotherapy, Candida albicans, Candida tropicalis, Candida glabrata, minimum inhibitory concentration, minimum fungicidal concentration, drug repurposing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review